Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 215, Issue suppl_1, Pages S44-S51
Publisher
Oxford University Press (OUP)
Online
2017-02-15
DOI
10.1093/infdis/jiw299
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of multidrug resistance on the pathogenicity of Pseudomonas aeruginosa: in vitro and in vivo studies
- (2016) Silvia Gómez-Zorrilla et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Prospective Observational Study of Prior Rectal Colonization Status as a Predictor for Subsequent Development of Pseudomonas aeruginosa Clinical Infections
- (2015) Silvia Gómez-Zorrilla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins
- (2015) M. Berrazeg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Host genetic diversity influences the severity of Pseudomonas aeruginosa pneumonia in the Collaborative Cross mice
- (2015) Nicola Ivan Lorè et al. BMC GENETICS
- The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
- (2015) Xian-Zhi Li et al. CLINICAL MICROBIOLOGY REVIEWS
- The increasing threat of Pseudomonas aeruginosa high-risk clones
- (2015) Antonio Oliver et al. DRUG RESISTANCE UPDATES
- Antibiotic Pressure Is a Major Risk Factor for Rectal Colonization by Multidrug-Resistant Pseudomonas aeruginosa in Critically Ill Patients
- (2014) Silvia Gómez-Zorrilla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Overexpression of MexCD-OprJ Reduces Pseudomonas aeruginosa Virulence by Increasing Its Susceptibility to Complement-Mediated Killing
- (2014) Inmaculada Martínez-Ramos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Virulence Genotype and Resistance Profile in the Mortality of Pseudomonas aeruginosa Bloodstream Infections
- (2014) C. Pena et al. CLINICAL INFECTIOUS DISEASES
- Risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa: clinical impact of bacterial virulence and strains on outcome
- (2014) Su Jin Jeong et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009–2012
- (2014) Helio S. Sader et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Prevalence of Type III Secretion Protein Exoenzymes and Antimicrobial Susceptibility Patterns from Bloodstream Isolates of Patients withPseudomonas aeruginosaBacteremia
- (2014) K.W. Garey et al. JOURNAL OF CHEMOTHERAPY
- Rearrangement of a Large Novel Pseudomonas aeruginosa Gene Island in Strains Isolated from a Patient Developing Ventilator-Associated Pneumonia
- (2014) G. Singh et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
- (2014) Abiola O. Olaitan et al. Frontiers in Microbiology
- Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones
- (2013) Xavier Mulet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bacterial and Clinical Characteristics of Health Care- and Community-Acquired Bloodstream Infections Due to Pseudomonas aeruginosa
- (2013) Angela Hattemer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort
- (2013) Carmen Peña et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World?
- (2013) A. Beceiro et al. CLINICAL MICROBIOLOGY REVIEWS
- Risk of Developing Pneumonia Is Enhanced by the Combined Traits of Fluoroquinolone Resistance and Type III Secretion Virulence in Respiratory Isolates of Pseudomonas aeruginosa*
- (2013) Eva Sullivan et al. CRITICAL CARE MEDICINE
- Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study
- (2013) Mikhail V Edelstein et al. LANCET INFECTIOUS DISEASES
- Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing
- (2013) D. Skurnik et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The complex pathogenesis of bacteremia
- (2013) Eirini Christaki et al. Virulence
- Pseudomonas aeruginosa: new insights into pathogenesis and host defenses
- (2013) Shaan L. Gellatly et al. Pathogens and Disease
- Quantitative Contributions of Target Alteration and Decreased Drug Accumulation to Pseudomonas aeruginosa Fluoroquinolone Resistance
- (2012) Sebastian Bruchmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones
- (2012) Gabriel Cabot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Multiple Signaling Systems Regulating Virulence in Pseudomonas aeruginosa
- (2012) P. Nadal Jimenez et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Human genetic susceptibility to infectious disease
- (2012) Stephen J. Chapman et al. NATURE REVIEWS GENETICS
- A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence
- (2012) Deepak Balasubramanian et al. NUCLEIC ACIDS RESEARCH
- Differentiation in Quinolone Resistance by Virulence Genotype in Pseudomonas aeruginosa
- (2012) Melissa Agnello et al. PLoS One
- Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study
- (2011) Gabriel Cabot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective Multicenter Study of the Impact of Carbapenem Resistance on Mortality in Pseudomonas aeruginosa Bloodstream Infections
- (2011) Carmen Peña et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical outcomes of type III Pseudomonas aeruginosa bacteremia*
- (2011) Ali A. El-Solh et al. CRITICAL CARE MEDICINE
- A model to predict mortality following Pseudomonas aeruginosa bacteremia
- (2011) Elizabeth B. Hirsch et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Status report on carbapenemases: challenges and prospects
- (2011) Gopi Patel et al. Expert Review of Anti-Infective Therapy
- Effect of multidrug resistance-conferring mutations on the fitness and virulence of Pseudomonas aeruginosa
- (2011) K. Abdelraouf et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem
- (2011) E. Riera et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Most Multidrug-Resistant Pseudomonas aeruginosa Isolates from Hospitals in Eastern France Belong to a Few Clonal Types
- (2011) Pascal Cholley et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Risk Factors for Mortality in Patients with Pseudomonas aeruginosa Bacteremia: Clinical Impact of Antimicrobial Resistance on Outcome
- (2011) Eun-Jeong Joo et al. Microbial Drug Resistance
- Population Structure of Pseudomonas aeruginosa from Five Mediterranean Countries: Evidence for Frequent Recombination and Epidemic Occurrence of CC235
- (2011) Makaoui Maatallah et al. PLoS One
- Pseudomonas aeruginosa: all roads lead to resistance
- (2011) Elena B.M. Breidenstein et al. TRENDS IN MICROBIOLOGY
- Pseudomonas Aeruginosa: Resistance to the Max
- (2011) Keith Poole Frontiers in Microbiology
- A Two-Component Regulatory System Interconnects Resistance to Polymyxins, Aminoglycosides, Fluoroquinolones, and β-Lactams inPseudomonas aeruginosa
- (2010) Cédric Muller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient Outcomes
- (2010) V. H. Tam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pathogenicity Islands PAPI-1 and PAPI-2 Contribute Individually and Synergistically to the Virulence of Pseudomonas aeruginosa Strain PA14
- (2010) E. M. Harrison et al. INFECTION AND IMMUNITY
- Protein secretion systems in Pseudomonas aeruginosa: A wealth of pathogenic weapons
- (2010) Sophie Bleves et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Antibiotic resistance and its cost: is it possible to reverse resistance?
- (2010) Dan I. Andersson et al. NATURE REVIEWS MICROBIOLOGY
- Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
- (2009) P. D. Lister et al. CLINICAL MICROBIOLOGY REVIEWS
- Stratification is the key: Inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis*
- (2009) Marcin F. Osuchowski et al. CRITICAL CARE MEDICINE
- The type III secretion system of Pseudomonas aeruginosa: infection by injection
- (2009) Alan R. Hauser NATURE REVIEWS MICROBIOLOGY
- β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
- (2009) Bartolomé Moya et al. PLoS Pathogens
- Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa
- (2008) A. Wong-Beringer et al. CLINICAL MICROBIOLOGY AND INFECTION
- Genomic islands ofPseudomonas aeruginosa
- (2008) Scott E. Battle et al. FEMS MICROBIOLOGY LETTERS
- Hybrid Pathogenicity Island PAGI-5 Contributes to the Highly Virulent Phenotype of a Pseudomonas aeruginosa Isolate in Mammals
- (2008) S. E. Battle et al. JOURNAL OF BACTERIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More